Clinical Trials · NCT03628066
Biological and Clinical Effects of Palbociclib With Ovarian Suppression and Letrozole in the Neoadjuvant Treatment of Breast Cancer
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- NSABP Foundation Inc
- Enrollment
- 24
- Start date
- Oct 2018
- Locations
- 15 sites, United States, Canada
- Primary endpoint
- Complete Cell cycle arrest